Skip to main content
Regent Pacific Group Limited logo

Regent Pacific Group Limited — Investor Relations & Filings

Ticker · 575 ISIN · KYG3042R1314 LEI · 549300TF362HOIC4TJ34 HKEX Financial and insurance activities
Open in API
Filings indexed 1,267 across all filing types
Latest filing 2020-11-18 Proxy Solicitation & In…
Country KY Cayman Islands
Listing HKEX 575

About Regent Pacific Group Limited

http://www.regentpac.com

Regent Pacific Group Limited is an investment holding company primarily focused on the healthcare and life sciences sectors globally. The company specializes in growth and value-led investments, particularly targeting late-stage life sciences assets and biopharma companies. Its core strategy involves building a powerful portfolio of investments intended for commercialization, often achieved through out-licensing agreements with strategic pharmaceutical partners. Regent Pacific operates across key markets, including Europe, the United States, and the Asia Pacific region. A significant area of focus is the longevity medicine business, which utilizes advanced AI technology following the acquisition of Deep Longevity Inc., positioning the company as an engine for emerging AI-driven biopharma solutions.

Recent filings

Filing Released Lang Actions
Form of Proxy for use at the Extraordinary General Meeting to be held on 9 December 2020
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for use at an Extraordinary General Meeting (EGM) of Regent Pacific Group Limited. It includes instructions for shareholders to appoint proxies to vote on resolutions at the EGM, specifically regarding the approval of the issue and allotment of shares. This type of document is a solicitation for shareholder votes and provides information necessary for voting at a meeting, rather than reporting financial results or management commentary. It is not an announcement of voting results, nor is it a report or presentation. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length and content confirm it is not a brief announcement or a report publication notice.
2020-11-18 English
Discloseable Transaction: Acquisition of Deep Longevity, Inc.
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed circular from Regent Pacific Group Limited regarding a discloseable transaction, specifically the acquisition of Deep Longevity, Inc. It includes a notice convening an extraordinary general meeting (EGM) for shareholder approval related to the transaction, proxy form instructions, definitions, and a letter from the board. The presence of an EGM notice and detailed transaction information indicates this is a circular sent to shareholders to inform and solicit votes on a specific corporate action. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or notice of a report publication. Therefore, it is not a simple announcement (RPA) or regulatory filing (RNS). It is not an annual or interim report, earnings release, or other financial report type. The focus on the transaction and the EGM notice aligns with PSI.
2020-11-18 English
Operations update on Fortacin
Regulatory Filings Classification · 95% confidence The document is an announcement dated 17 November 2020 from Regent Pacific Group Limited providing an update on the operational progress of their product Fortacin™. It references previous interim results announcements and discusses regulatory approval progress in China, the US, Taiwan, Hong Kong, and Macau. The document includes details about clinical trials, regulatory submissions, and commercial partnerships but does not contain actual financial statements or detailed financial analysis. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a call transcript or audit report. The document is longer than 5,000 characters and provides substantive operational updates rather than just announcing the publication of a report. It is an operational update announcement, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-11-17 English
Further delay in despatch of the circular relating to Discloseable Transaction: Acquisition of Deep Longevity, Inc.
Regulatory Filings Classification · 95% confidence The document is an announcement dated 4 November 2020 from Regent Pacific Group Limited regarding a further delay in the despatch of a circular related to a discloseable transaction (acquisition of Deep Longevity, Inc.). It mentions the postponement of the circular's despatch date and the scheduling of an Extraordinary General Meeting. The document does not contain financial statements or detailed financial data but is an update on the timing of a shareholder circular and meeting related to a transaction. It is not the circular itself, nor a full report or financial filing. The content fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about the delay and scheduling of corporate actions without substantive financial data or report content.
2020-11-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2020 and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The document includes confirmations related to compliance with listing rules and legal requirements. The content focuses on share capital changes and securities movements rather than financial performance, management commentary, or regulatory certifications. It is a regulatory filing reporting monthly share capital movements to the stock exchange, not an annual or interim report, earnings release, or management discussion. The document is lengthy (over 14,000 characters) and contains detailed data on share capital changes, consistent with a regulatory filing rather than a report publication announcement or certification. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement about share capital movements that does not fit more specific categories like Share Issue/Capital Change (SHA) because it is a monthly return report rather than a single announcement of a capital change event.
2020-11-02 English
Further delay in despatch of the circular relating to Discloseable Transaction: Acquisition of Deep Longevity, Inc.
Regulatory Filings Classification · 95% confidence The document is an announcement dated 21 October 2020 from Regent Pacific Group Limited regarding a further delay in the despatch of a circular related to a discloseable transaction (acquisition of Deep Longevity, Inc.). It mentions the postponement of the circular's despatch date and the scheduling of an Extraordinary General Meeting. The document does not contain financial statements or detailed financial data but is an update on the timing of a shareholder circular and meeting related to a transaction. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about the delay and scheduling of corporate actions, not the actual circular or transaction documents themselves.
2020-10-21 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.